SNCA (aa 1-10) Specific Recomb™ Antibody (V3S-1023-FY136), Human IgG (CAT#: V3S-1023-FY136)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human antibody that specifically targets human SNCA. It attaches to α-syn residues 1-10. It exhibits a remarkable preference for aggregated forms of α-syn, displaying an apparent affinity that is at least 800 times higher for fibrillar α-syn compared to monomeric recombinant α-syn. Furthermore, it demonstrates a strong affinity for human PD brain tissue, effectively distinguishing between monomers and oligomeric/fibrillar forms of α-syn due to its high avidity for aggregates. This avidity is a result of its weak monovalent affinity and rapid binding kinetics.
Clonality Monoclonal
Host Species Human
Target Species Human
Epitope AA 1-10
Affinity KD = 120 pM
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; FuncS; IHC; DB
Application Notes IHC: 2-8 μg/mL
Dot blot: 1.25 μg/mL

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target SNCA
Alternative Name PD1; NACP; PARK1; PARK4; alpha-synuclein; I+/--synuclein; non A-beta component of AD amyloid; synuclein alpha-140; synuclein, alpha (non A4 component of amyloid precursor); truncated alpha synuclein
Gene ID 6622
UniProt P37840
Research Area Cancer Research
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry